Julianne Bruno

Companies

• Damora Therapeutics, Inc.Board member Nov 17, 2025 to now¹
• CRISPR TherapeuticsChief operating officer May 23, 2024 to Mar 24, 2025²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• DTDamora Therapeutics, Inc. DMRA137,032 shares³$2.5M at $18.32Feb 9, 2026
• CRISPR Therapeutics CRSP17,632 shares⁴$880.0K at $49.91Mar 24, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 9, 2026Exercised options 129,000 shares of Damora Therapeutics, Inc.³
• Mar 21, 2025Sold 1,714 shares at $41.23 of CRISPR Therapeutics⁴
• Mar 20, 2025Exercised options 3,750 shares of CRISPR Therapeutics⁴
• Mar 12, 2025Sold 190 shares at $43.32 of CRISPR Therapeutics⁵
• Mar 11, 2025Exercised options 435 shares of CRISPR Therapeutics⁵
• Mar 11, 2025Sold 1,198 shares at $42.42 of CRISPR Therapeutics⁵
• Mar 10, 2025Exercised options 2,399 shares of CRISPR Therapeutics⁵
• Feb 19, 2025Sold 333 shares at $52.80 of CRISPR Therapeutics⁶
• Feb 18, 2025Exercised options 650 shares of CRISPR Therapeutics⁶
• Jun 21, 2024Sold 3,366 shares at $56.09 of CRISPR Therapeutics⁷
• Jun 20, 2024Exercised options 7,000 shares of CRISPR Therapeutics⁷